IDF President-Elect meets Dr. Jitendra Singh to boost indigenous biosimilar insulin production and diabetes biomanufacturing in India, focusing on affordability, supply security, and industry collaboration.
Type 1 Diabetes Insulin Access | 08/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy